JD Health International Inc.
JDHIY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $35,290 | $29,816 | $28,344 | $26,420 |
| % Growth | 18.4% | 5.2% | 7.3% | – |
| Cost of Goods Sold | $26,398 | $23,207 | $21,644 | $20,757 |
| Gross Profit | $8,892 | $6,609 | $6,700 | $5,662 |
| % Margin | 25.2% | 22.2% | 23.6% | 21.4% |
| R&D Expenses | $736 | $685 | $645 | $610 |
| G&A Expenses | $612 | $734 | $685 | $561 |
| SG&A Expenses | $6,028 | $5,795 | $5,020 | $5,301 |
| Sales & Mktg Exp. | $1,809 | $1,644 | $1,404 | $730 |
| Other Operating Expenses | $0 | -$316 | $0 | $0 |
| Operating Expenses | $6,765 | $6,165 | $5,665 | $5,911 |
| Operating Income | $2,127 | $444 | $1,035 | -$248 |
| % Margin | 6% | 1.5% | 3.7% | -0.9% |
| Other Income/Exp. Net | $737 | $1,914 | $1,404 | $679 |
| Pre-Tax Income | $2,864 | $2,357 | $2,439 | $901 |
| Tax Expense | $272 | $235 | $405 | $281 |
| Net Income | $2,596 | $2,125 | $2,037 | $580 |
| % Margin | 7.4% | 7.1% | 7.2% | 2.2% |
| EPS | 0.82 | 0.68 | 0.65 | 0.18 |
| % Growth | 20.6% | 4.6% | 261.1% | – |
| EPS Diluted | 0.81 | 0.67 | 0.65 | 0.18 |
| Weighted Avg Shares Out | 3,205 | 3,140 | 3,140 | 3,189 |
| Weighted Avg Shares Out Dil | 3,190 | 3,156 | 3,156 | 3,189 |
| Supplemental Information | – | – | – | – |
| Interest Income | $804 | -$19 | $1,979 | $1,013 |
| Interest Expense | $0 | $0 | $8 | $5 |
| Depreciation & Amortization | $120 | $111 | $103 | $120 |
| EBITDA | $2,247 | $3,881 | $1,138 | -$5 |
| % Margin | 6.4% | 13% | 4% | -0% |